SCHEMBL1634646

SCHEMBL1634646

COc1cc(OC)c(/C=C/S(=O)(=O)Nc2ccc(OC)c(OS(=O)(=O)c3ccc([N+](=O)[O-])cc3[N+](=O)[O-])c2)c(OC)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.44
ALDH1A1 P00352 5/20 0.40
POLB P06746 3/20 0.40
LMNA P02545 2/20 0.40
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
MAPT P10636 3/20 0.40
MAPK1 P28482 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
BLM P54132 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALPL P05186 1/20 0.37
PTGS2 P35354 2/20 0.36
PTGS1 P23219 1/20 0.36
THRB P10828 1/20 0.36
CYP19A1 P11511 1/20 0.36
TBXA2R P21731 1/20 0.35
TLR9 Q9NR96 1/20 0.35
SETD7 Q8WTS6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1634055 0.84 KMT2A (0.46) HPGDALDH1A1POLBLMNAMEN1
SCHEMBL1634897 0.82 PLK1 (0.48) HPGDALDH1A1POLBLMNAMEN1
SCHEMBL2212628 0.81 TUBB4A (0.48) ALDH1A1POLBLMNAMEN1KMT2A
SCHEMBL2212619 0.81 TUBB4A (0.48) ALDH1A1POLBLMNAMEN1KMT2A
SCHEMBL1122695 0.81 PTGS2 (0.51) HPGDALDH1A1POLBLMNAMEN1
SCHEMBL1637074 0.80 LMNA (0.47) HPGDALDH1A1LMNAMAPTMAPK1
SCHEMBL4655381 0.79 HPGD (0.43) HPGDALDH1A1POLBLMNAMEN1
SCHEMBL1635270 0.79 LMNA (0.38) ALDH1A1LMNAMEN1KMT2AMAPT
SCHEMBL1634600 0.78 MAPT (0.46) HPGDALDH1A1POLBLMNAMEN1
SCHEMBL1634604 0.78 MAPT (0.46) HPGDALDH1A1POLBLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080058290-A1 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2008-03-06 US claimed
EP-3138832-A1 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS Temple University - Of The Commonwealth System of Higher Education (US) 2017-03-08 EP disclosed
US-7932242-B2 Anticancer agents; radiation and chemical resistance TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2011-04-26 US disclosed
US-20080058290-A1 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2008-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058290-A1 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders PCNA, MKI67, TP53 HPGD 133/4885ALDH1A1 564/4885POLB 81/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.